{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:54:57Z","timestamp":1781848497535,"version":"3.54.5"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    Pancreatic cancer is a highly lethal gastrointestinal malignancy with chemotherapy resistance as a major obstacle to improving prognosis. Emerging evidence indicates that the intratumoral microbiome is closely implicated in the development, progression, and therapeutic response of pancreatic cancer. The intratumoral microbiome of pancreatic cancer is mainly composed of\n                    <jats:italic>Proteobacteria<\/jats:italic>\n                    and\n                    <jats:italic>Firmicutes<\/jats:italic>\n                    , and its composition is significantly correlated with patient survival. Intratumoral microbes drive tumor progression by remodeling the immune microenvironment, inducing DNA damage, and activating oncogenic signaling pathways. Meanwhile, they exacerbate chemotherapy resistance via multiple mechanisms, including remodeling the extracellular matrix, establishing an immunosuppressive microenvironment, and metabolically inactivating chemotherapeutic agents. This review systematically summarizes the community composition of the intratumoral microbiome in pancreatic cancer, its regulatory effects, and underlying mechanisms on chemotherapy resistance, as well as the latest advances in targeted therapeutic strategies.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2026.1860523","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:48:15Z","timestamp":1781848095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intratumoral microbiome: a key regulator and novel therapeutic target for chemoresistance in pancreatic cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Yunpeng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Mianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Mianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00535-023-02069-5","article-title":"Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma","volume":"59","author":"Abe","year":"2024","journal-title":"J. Gastroenterol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","article-title":"Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer","volume":"40","author":"Alam","year":"2022","journal-title":"Cancer Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s12885-019-5803-1","article-title":"Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells","volume":"19","author":"Amrutkar","year":"2019","journal-title":"BMC Cancer."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1245\/s10434-025-17062-w","article-title":"Preoperative prognostic factors in resectable pancreatic cancer: state of the art and prospects","volume":"32","author":"Boubaddi","year":"2025","journal-title":"Ann. Surg. Oncol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/1533033819867354","article-title":"Role of oral microbiome signatures in diagnosis and prognosis of oral cancer","volume":"18","author":"Chattopadhyay","year":"2019","journal-title":"Technol. Cancer Res. Treat."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105661","article-title":"Intratumoural pks(+)Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndrome","volume":"114","author":"Chu","year":"2025","journal-title":"EBioMedicine"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2320280","article-title":"Roles of microbiota in pancreatic cancer development and treatment","volume":"16","author":"Cruz","year":"2024","journal-title":"Gut Microbes"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2374596","article-title":"Microbiome and pancreatic cancer: time to think about chemotherapy","volume":"16","author":"de Castilhos","year":"2024","journal-title":"Gut Microbes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S326","DOI":"10.1086\/513850","article-title":"How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses","volume":"179","author":"Ernst","year":"1999","journal-title":"J. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40890","article-title":"Antitumor potentials of onco-microbial in Chinese patients with pancreatic cancer","volume":"10","author":"Gao","year":"2024","journal-title":"Heliyon"},{"key":"B12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/gutjnl-2021-324031","article-title":"Composition, diversity and potential utility of intervention-naive pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound","volume":"71","author":"Gleeson","year":"2022","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s10565-022-09736-y","article-title":"miR-222-3p-containing macrophage-derived extracellular vesicles confer gemcitabine resistance via TSC1-mediated mTOR\/AKT\/PI3K pathway in pancreatic cancer","volume":"39","author":"Guo","year":"2023","journal-title":"Cell Biol. Toxicol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1038\/s41467-024-51534-z","article-title":"Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer","volume":"15","author":"Han","year":"2024","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1111\/cas.15901","article-title":"Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis","volume":"114","author":"Hayashi","year":"2023","journal-title":"Cancer Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658681","article-title":"Fusobacterium nucleatum facilitates M2 macrophage polarization and colorectal carcinoma progression by activating TLR4\/NF-kappaB\/S100A9 cascade","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.785422","article-title":"Intratumor microbiome analysis identifies positive association between Megasphaera and survival of Chinese patients with pancreatic ductal adenocarcinomas","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","author":"Human Microbiome Project","year":"2012","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12964-023-01134-z","article-title":"Intratumoural microbiota: from theory to clinical application","volume":"21","author":"Ji","year":"2023","journal-title":"Cell. Commun. Signal."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.376","article-title":"Intratumor microbiome: selective colonization in the tumor microenvironment and a vital regulator of tumor biology","volume":"4","author":"Jiang","year":"2023","journal-title":"MedComm (2020)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216031","article-title":"Intratumoral microbiota: a new force in diagnosing and treating pancreatic cancer","volume":"554","author":"Jiang","year":"2023","journal-title":"Cancer Lett."},{"key":"B26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4248\/IJOS11075","article-title":"Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma","volume":"3","author":"Katz","year":"2011","journal-title":"Int. J. Oral. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.chom.2013.12.010","article-title":"Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE(2)","volume":"15","author":"Kim","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/diseases14020042","article-title":"Microbiota transplantation as a future novel therapeutic strategy approach","volume":"14","author":"Kumar","year":"2026","journal-title":"Diseases"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/srep14554","article-title":"Local bacteria affect the efficacy of chemotherapeutic drugs","volume":"5","author":"Lehouritis","year":"2015","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12672-024-01320-6","article-title":"Intratumoral microbiota of pancreatic ductal adenocarcinoma impact patient prognosis by influencing tumor microenvironment","volume":"15","author":"Leng","year":"2024","journal-title":"Discov. Oncol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.928846","article-title":"An exploration of oral-gut pathogens mediating immune escape of pancreatic cancer via miR-21\/PTEN axis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1548027","article-title":"Fecal microbiota transplantation augments 5-fluorouracil efficacy in pancreatic cancer via gut microbiota modulation","volume":"16","author":"Li","year":"2025","journal-title":"Front. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1007\/s10120-021-01202-8","article-title":"Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4\/PI3K\/Akt signaling","volume":"24","author":"Li","year":"2021","journal-title":"Gastric Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e003069","DOI":"10.1136\/jitc-2021-003069","article-title":"Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma","volume":"10","author":"Liu","year":"2022","journal-title":"J. ImmunoTher. Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2340124","article-title":"Novel discoveries targeting pathogenic gut microbes and new therapies in pancreatic cancer: does pathogenic E. coli infection cause pancreatic cancer progression modulated by TUBB\/Rho\/ROCK signaling pathway? A bioinformatic analysis","volume":"2020","author":"Luo","year":"2020","journal-title":"BioMed. Res. Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1001\/jamasurg.2023.7872","article-title":"Implementation of best practices in pancreatic cancer care in the Netherlands: a stepped-wedge randomized clinical trial","volume":"159","author":"Mackay","year":"2024","journal-title":"JAMA Surg."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216502","article-title":"Gut microbiota and bacterial translocation in the pathogenesis of liver fibrosis","volume":"24","author":"Maslennikov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn0704","article-title":"The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer","volume":"7","author":"Mirji","year":"2022","journal-title":"Sci. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010157","article-title":"Pancreatic cancer resistance to treatment: the role of microbiota","volume":"11","author":"Nista","year":"2023","journal-title":"Biomedicines"},{"key":"B41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.pan.2023.07.008","article-title":"Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma","volume":"23","author":"Pfisterer","year":"2023","journal-title":"Pancreatology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"B43","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e20192282","DOI":"10.1084\/jem.20192282","article-title":"Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling","volume":"217","author":"Shi","year":"2020","journal-title":"J. Exp. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA: A. Cancer J. For. Clin."},{"key":"B48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s43018-025-01067-1","article-title":"Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinoma","volume":"7","author":"Silver","year":"2026","journal-title":"Nat. Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1434771","article-title":"Unraveling the gut microbiome's contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives","volume":"15","author":"Tabrizi","year":"2024","journal-title":"Front. Immunol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13020452","article-title":"Could the microbial profiling of normal pancreatic tissue from healthy organ donors contribute to understanding the intratumoral microbiota signature in pancreatic ductal adenocarcinoma","volume":"13","author":"Tavano","year":"2025","journal-title":"Microorganisms"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1002\/cam4.5323","article-title":"Role of microbiota and microbiota-derived short-chain fatty acids in PDAC","volume":"12","author":"Temel","year":"2023","journal-title":"Cancer Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.4049\/jimmunol.1002794","article-title":"Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo","volume":"186","author":"Thurlow","year":"2011","journal-title":"J. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abn4948","article-title":"Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling","volume":"15","author":"Udayasuryan","year":"2022","journal-title":"Sci. Signal."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1200\/JCO.21.02616","article-title":"Immunologic strategies in pancreatic cancer: Making cold tumors hot","volume":"40","author":"Ullman","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1158\/0008-5472.CAN-23-3987","article-title":"Cancer-associated fibroblasts expressing sulfatase 1 facilitate VEGFA-dependent microenvironmental remodeling to support colorectal cancer","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Res."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1726","article-title":"A combination of faecal and intratumour microbial community profiling reveals novel diagnostic and prognostic biomarkers for pancreatic tumours","volume":"14","author":"Wang","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12929-025-01117-x","article-title":"Intratumoral microbiome: Implications for immune modulation and innovative therapeutic strategies in cancer","volume":"32","author":"Wang","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s13238-020-00813-8","article-title":"Unexpected guests in the tumor microenvironment: microbiome in cancer","volume":"12","author":"Wong-Rolle","year":"2021","journal-title":"Protein Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"TPS759","DOI":"10.1200\/JCO.2023.41.4_suppl.TPS759","article-title":"A pilot study of gut microbiome modulation to enable efficacy of neoadjuvant checkpoint-based immunotherapy (IO) following chemotherapy in pancreatic ductal adenocarcinoma (PDAC)","volume":"41","author":"Wu","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12672-025-04309-x","article-title":"Integrative immunogenomic profiling identifies CALU as a brown adipocyte-linked modulator of progression and treatment response in pancreatic cancer","volume":"17","author":"Wu","year":"2026","journal-title":"Discov. Oncol."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1980347","article-title":"Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322\/CCL20 axis and M2 polarization","volume":"13","author":"Xu","year":"2021","journal-title":"Gut Microbes"},{"key":"B64","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12876-020-01351-7","article-title":"Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas harboring KRAS and BRCA mutations: case report and whole exome sequencing analysis","volume":"20","author":"Yang","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101464","article-title":"Gut microbiota metabolite 3-indolepropionic acid directly activates hepatic stellate cells by ROS\/JNK\/p38 signaling pathways","volume":"13","author":"Yuan","year":"2023","journal-title":"Biomolecules"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1501973","article-title":"The synthesis of the novel Escherichia coli toxin-colibactin and its mechanisms of tumorigenesis of colorectal cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Microbiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"28403","DOI":"10.1038\/s41598-025-13811-9","article-title":"Synchronous surgery combined preoperative chemotherapy benefits patients suffering pancreatic ductal adenocarcinoma with liver metastases: a systematic review and meta-analysis","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci. Rep."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216457","article-title":"A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance","volume":"578","author":"Zhou","year":"2023","journal-title":"Cancer Lett."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1126\/science.aar6918","article-title":"The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies","volume":"359","author":"Zitvogel","year":"2018","journal-title":"Science"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1860523\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:48:16Z","timestamp":1781848096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1860523\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":69,"alternative-id":["10.3389\/fcimb.2026.1860523"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1860523","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"article-number":"1860523"}}